As our studies do not unequivocally exclude a potential role for other LOX/LOXL family members in human lung fibrosis an area of future study could be the systematic silencing of each LOX/LOXL family member using CRISPR gene editing. This evidence concerns the gene LOXL3 and pulmonary fibrosis.